US Bancorp DE Sells 2,427 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

US Bancorp DE cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 65,016 shares of the medical equipment provider's stock after selling 2,427 shares during the quarter. US Bancorp DE's holdings in Intuitive Surgical were worth $33,936,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC boosted its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its stake in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the firm's stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,598 shares of company stock valued at $7,223,467. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Up 1.8 %

Intuitive Surgical stock traded up $10.06 during midday trading on Wednesday, hitting $568.02. 2,038,885 shares of the stock were exchanged, compared to its average volume of 1,387,733. The stock has a market capitalization of $202.32 billion, a PE ratio of 88.61, a P/E/G ratio of 5.85 and a beta of 1.43. The company has a fifty day simple moving average of $571.70 and a two-hundred day simple moving average of $530.90. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective for the company. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Finally, Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.